Overview
John K. Fink, MD, is a professor in the Department of Neurology and director of the Neurogenetic Disorders Program in the University of Michigan Medical School. He directs basic science laboratory research focused on identifying genes and mechanisms responsible for age-dependent neurologic degeneration; and on developing treatments for these conditions.Fink's laboratory investigates the molecular basis of inherited neurologic and psychiatric disorders. His clinical expertise focuses on inherited and degenerative disorders of the nervous system. Dr. Fink evaluates individuals of all ages, from infancy through senescence with these disorders, which include lysosomal storage disorders (such as Gaucher disease, Niemann-Pick disease and Fabry disease), ataxias (including Friedreich's ataxia), leukodystrophies (such as Krabbe, CADASIL and adrenoleukodystrophy), familial dystonia, primary lateral sclerosis, Wilson's disease, familial motor neuron disease (including familial amyotrophic lateral sclerosis), familial dementia, and a group of inherited spinal cord disorders known collectively as the Hereditary Spastic Paraplegias (HSPs).Dr. Fink came to the University of Michigan in 1990 as an assistant professor of neurology and director of the Neurogenetic Disorders Clinic. The program provides care and evaluation for individuals and families with inherited and degenerative neurologic disorders; and clinical and molecular laboratory training for physicians and scientists studying these disorders. He was promoted to associate professor in 1996 and professor in 2005.Board-certified in neurology and medical genetics, Dr. Fink received his medical degree in 1980 from the Medical College of Ohio in Toledo. Following internship at the Mayo Clinic in Rochester, Minnesota, he completed a neurology residency in 1984 at the University of Virginia in Charlottesville. Subsequently, he trained in developmental and metabolic neurology and medical genetics at the National Institutes of Health.Dr. Fink has served as the Medical Advisor to the Spastic Paraplegia Foundation since its establishment (2002), and serves as ad hoc reviewer for numerous journals and NIH study sections.A member of the American Society of Human Genetics, American Academy of Neurology, American Neurological Association and the American College of Genetics, Dr. Fink received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2002. In addition, he has been elected by peers to Best Doctors in America annually since 2001.
Dr. Fink is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Spastic Paraplegia Type 2, Primary Lateral Sclerosis, and CACH Syndrome.
Dr. Fink is board certified in Clinical Genetics and Neurology. He is actively involved in clinical research, co-authoring 28 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor 1 Reception C, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Fink has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
C. S. Mott Children's Hospital
Ayesha Ahmad is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Ahmad is highly rated in 50 conditions, according to our data. Her clinical expertise encompasses Pompe Disease, Propionic Acidemia, Von Gierke Disease, and Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome). Dr. Ahmad is board certified in Clinical Biochemical Genetics and Clinical Genetics & Genomics.
Taubman Center
Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.
C. S. Mott Children's Hospital
Donna Martin is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Martin is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses CHARGE Syndrome, Autism Spectrum Disorder, Coloboma, and Ulnar-Mammary Syndrome.
Frequently Asked Questions about Dr. John K. Fink
How do I make an appointment with Dr. John K. Fink?
You can book an appointment with Dr. John K. Fink by calling their office at 734-936-9020. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John K. Fink a top-rated expert for Spastic Paraplegia Type 7?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John K. Fink is classified as an Distinguished expert for Spastic Paraplegia Type 7, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John K. Fink specialize in?
While Dr. John K. Fink is a Neurology, they have specific expertise in Spastic Paraplegia Type 7, Spastic Paraplegia Type 2, and Primary Lateral Sclerosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. John K. Fink participate in research or clinical trials?
Yes. Dr. John K. Fink has published 28 articles and abstracts on conditions like Spastic Paraplegia Type 7. You can view a list of Dr. John K. Fink's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John K. Fink accept my insurance?
Dr. John K. Fink accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-936-9020 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CACH SyndromeDr. Fink isDistinguished. Learn about CACH Syndrome.
- ParaplegiaDr. Fink isDistinguished. Learn about Paraplegia.
- Primary Lateral SclerosisDr. Fink isDistinguished. Learn about Primary Lateral Sclerosis.
- Spastic Paraplegia Type 2Dr. Fink isDistinguished. Learn about Spastic Paraplegia Type 2.
- Spastic Paraplegia Type 7Dr. Fink isDistinguished. Learn about Spastic Paraplegia Type 7.
- Advanced
- Acute Cerebellar AtaxiaDr. Fink isAdvanced. Learn about Acute Cerebellar Ataxia.
- Adrenoleukodystrophy (ALD)Dr. Fink isAdvanced. Learn about Adrenoleukodystrophy (ALD).
- Alexander DiseaseDr. Fink isAdvanced. Learn about Alexander Disease.
- Alpha MannosidosisDr. Fink isAdvanced. Learn about Alpha Mannosidosis.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- AspartylglucosaminuriaDr. Fink isAdvanced. Learn about Aspartylglucosaminuria.
- Experienced
- 2q37 Deletion SyndromeDr. Fink isExperienced. Learn about 2q37 Deletion Syndrome.
- 47 XYY SyndromeDr. Fink isExperienced. Learn about 47 XYY Syndrome.
- Aase SyndromeDr. Fink isExperienced. Learn about Aase Syndrome.
- Abruzzo-Erickson SyndromeDr. Fink isExperienced. Learn about Abruzzo-Erickson Syndrome.
- Acrodermatitis EnteropathicaDr. Fink isExperienced. Learn about Acrodermatitis Enteropathica.
- Acrorenal Mandibular SyndromeDr. Fink isExperienced. Learn about Acrorenal Mandibular Syndrome.